Ponuka pracovných pozícií
Zistite viac o príležitostiach v spoločnosti Novartis. Pre ďalšie pracovné ponuky v Novartis Gene Therapies (predtým AveXis) navštívte GTx Career Search .
Oznámenie pre uchádzačov o voľné pracovné miesta v USA. Zistite viac
Showing 1654 results
- Sort by Sort ascending
- Názov pracovnej pozície Sort ascending
- Oblasť pôsobenia
- Miesto výkonu práce
- Stránka
- Dátum pridania
| Názov pracovnej pozície Sort ascending | Oblasť pôsobenia | Miesto výkonu práce | Stránka | Dátum pridania |
|---|---|---|---|---|
| Ultra-Rare Disease Territory Account Specialist – Jersey City, NJ Regular (Sales), Full time | Sales | USA +Alternative Locations | Field Sales (USA) | Mar 24, 2026 |
| Director, Business Applications & AI Products Regular, Full time | General Management | USA | East Hanover | Mar 24, 2026 |
| Ultra-Rare Disease Territory Account Specialist – Jacksonville, FL Regular (Sales), Full time | Sales | USA +Alternative Locations | Field Sales (USA) | Mar 24, 2026 |
| Ultra-Rare Disease Territory Account Specialist – Indianapolis Regular (Sales), Full time | Sales | USA | Field Sales (USA) | Mar 24, 2026 |
| Ultra-Rare Disease Territory Account Specialist – Cincinnati Regular (Sales), Full time | Sales | USA | Field Sales (USA) | Mar 24, 2026 |
| Ultra-Rare Disease Territory Account Specialist – Hartford, CT Regular (Sales), Full time | Sales | USA +Alternative Locations | Field Sales (USA) | Mar 24, 2026 |
| Raziskovalec MS&T (m/ž/d) / Scientist MS&T (m/f/d) - Upstream Process Regular, Full time | Production / Manufacturing | Slovenia | Mengeš | Mar 24, 2026 |
| Renal / Rare Disease Territory Account Specialist – ST. LOUIS, MO Regular (Sales), Full time | General Management | USA +Alternative Locations | Field Sales (USA) | Mar 24, 2026 |
| Ultra-Rare Disease Territory Account Specialist- Richmond Regular (Sales), Full time | Sales | USA | Field Sales (USA) | Mar 24, 2026 |
| Director, Marketing Strategy - Radioligand Therapy Regular, Full time | General Management | USA | East Hanover | Mar 24, 2026 |